Loading...
Delota Corp.
SYDRF•PNK
Healthcare
Medical - Pharmaceuticals
$0.08
$0.00(0.00%)
Delota Corp. (SYDRF) Financial Performance & Income Statement Overview
Review Delota Corp.’s income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns.
Revenue Growth
31.35%
↑ 31.35%
Operating Income Growth
-12.20%
↓ 12.20%
Net Income Growth
-125.97%
↓ 125.97%
Operating Cash Flow Growth
-33.89%
↓ 33.89%
Operating Margin
3.64%
↑ 3.64%
Gross Margin
38.62%
↑ 38.62%
Net Profit Margin
1.74%
↑ 1.74%
ROE
96.50%
↑ 96.50%
ROIC
18.99%
↑ 18.99%
Delota Corp. (SYDRF) Income Statement & Financial Overview
Review Delota Corp.'s (SYDRF) income statement with detailed quarterly and annual figures.
| Metric | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 |
|---|---|---|---|---|
| Revenue | $10.29M | $7.07M | $7.18M | $10.15M |
| Cost of Revenue | $6.41M | $4.15M | $4.33M | $6.33M |
| Gross Profit | $3.88M | $2.92M | $2.85M | $3.82M |
| Gross Profit Ratio | $0.38 | $0.41 | $0.40 | $0.38 |
| R&D Expenses | $0.00 | $0.00 | $0.00 | $0.00 |
| SG&A Expenses | $3.09M | $2.39M | $2.48M | $2.81M |
| Operating Expenses | $3.66M | $2.39M | $2.48M | $3.82M |
| Total Costs & Expenses | $10.07M | $6.54M | $6.81M | $10.15M |
| Interest Income | $0.00 | $0.00 | $0.00 | -$484291.00 |
| Interest Expense | $369131.00 | $0.00 | $0.00 | $365033.00 |
| Depreciation & Amortization | $396728.00 | $82740.00 | $85498.00 | $434449.00 |
| EBITDA | $1.22M | $319181.00 | $168333.00 | -$176037.00 |
| EBITDA Ratio | $0.12 | $0.05 | $0.02 | -$0.02 |
| Operating Income | $214831.00 | $524331.00 | $371492.00 | $573714.00 |
| Operating Income Ratio | $0.02 | $0.07 | $0.05 | $0.06 |
| Other Income/Expenses (Net) | $244152.00 | -$288792.00 | -$752194.00 | -$1.55M |
| Income Before Tax | $458983.00 | $235539.00 | -$380702.00 | -$975519.00 |
| Income Before Tax Ratio | $0.04 | $0.03 | -$0.05 | -$0.10 |
| Income Tax Expense | -$15945.00 | $11547.00 | $11580.00 | -$15944.00 |
| Net Income | $474928.00 | $247086.00 | -$369121.00 | -$959575.00 |
| Net Income Ratio | $0.05 | $0.03 | -$0.05 | -$0.09 |
| EPS | $0.01 | $0.007 | -$0.01 | -$0.04 |
| Diluted EPS | $0.02 | $0.008 | -$0.01 | -$0.04 |
| Weighted Avg Shares Outstanding | $34.12M | $34.12M | $28.90M | $27.46M |
| Weighted Avg Shares Outstanding (Diluted) | $29.60M | $29.60M | $28.90M | $27.46M |
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan